Fondaparinux

Singh Sindhu; Peter Silberstein

doi:10.1016/B978-008055232-3.64063-2

Fondaparinux

Singh Sindhu, Peter Silberstein

Department of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008

Original language	English (US)
Title of host publication	xPharm
Subtitle of host publication	The Comprehensive Pharmacology Reference
Publisher	Elsevier Inc.
Pages	1-6
Number of pages	6
ISBN (Print)	9780080552323
DOIs	https://doi.org/10.1016/B978-008055232-3.64063-2
State	Published - Jan 1 2008

Fingerprint

All Science Journal Classification (ASJC) codes

Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Sindhu, S., & Silberstein, P. (2008). Fondaparinux. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-6). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.64063-2

@inbook{591b60da4d9748ac8a60b8ce93ff0e07,

title = "Fondaparinux",

abstract = "Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin {\textcopyright} 2008",

author = "Singh Sindhu and Peter Silberstein",

year = "2008",

month = jan,

day = "1",

doi = "10.1016/B978-008055232-3.64063-2",

language = "English (US)",

isbn = "9780080552323",

pages = "1--6",

booktitle = "xPharm",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Fondaparinux

AU - Sindhu, Singh

AU - Silberstein, Peter

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008

AB - Fondaparinux, an anticoagulant, is a synthetic and specific inhibitor of activated Factor X (Xa). It binds to antithrombin (AT), increasing the affinity of AT affinity for (Xa). Fondaparinux belongs to the class of newer anticoagulants. Fondaparinux is a synthetic pentasaccharide; it is extensively sulfated and its sequence is derived from the AT binding region of heparin © 2008

UR - http://www.scopus.com/inward/record.url?scp=84883948992&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883948992&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.64063-2

DO - 10.1016/B978-008055232-3.64063-2

M3 - Chapter

SN - 9780080552323

SP - 1

EP - 6

BT - xPharm

PB - Elsevier Inc.

ER -

Access to Document

10.1016/B978-008055232-3.64063-2